Neal D. Shore, MD, FACS Discusses Impact, Treatment Implications of the Phase III HERO Trial

The Carolina Urologic Research Center expert discusses the benefits of oral relugolix for patients with prostate cancer.

Source: CancerNetwork - June 4, 2020 Category: Cancer & Oncology Authors: Neal D. Shore, MD, FACS Source Type: news